The use of adenovirus type 5 (Ad5) for cancer therapy is limited by deficiency of its primary cell attachment receptor, coxsackie and adenovirus receptor (CAR), on cancer cells. Ad5 retargeting to alternate receptors through fiber genetic modification can be used to circumvent CAR dependence of its tropism, and thereby achieve infectivity enhancement. Here we propose and test a novel ''complex mosaicism'' approach for fiber modification, which combines serotype chimerism with peptide ligand(s) incorporation in a single-fiber molecule. We incorporated integrin-binding peptide RGD-4C in the HI-loop, at the carboxy (C)-terminus, or both locales of the Ad3 knob, in the context of Ad5/3 chimera fiber in order to retarget simultaneously the Ad vector to integrins and Ad3 receptors. The infectivity enhancement of the fiber modifications was assessed in various cancer cell lines as cancer-targeting models. Replication-defective complex mosaic Ad-luc vectors bearing chimeric fiber (F.5/3), with or without C-terminal RGDmodification of Ad3 knob, demonstrated up to 55-fold gene transfer increase in bladder cancer cell lines. Although this augmentation was primarily due to Ad3 receptor targeting, some contribution of RGD-mediated integrin-targeting was also observed, suggesting that complex mosaic modification can function in a dual-receptor targeting via a single Ad3 fiber knob.
R ecombinant viruses based on adenovirus type 5 (Ad5) have been widely used as gene therapy vectors owing to their ability to infect a wide variety of cell types, propagate to high titers in vitro and support efficient expression of transgenes. 1 Other important advantages of Ad vectors include a high genomic capacity for transgene incorporation and therapeutic safety, since Ad5 does not integrate into the genome of infected cell.
Utilization of Ad5 for cancer therapy is, however, limited by the resistance of many types of cancer cells to Ad5 infection due to a paucity of the primary receptor for Ad5, the coxsackie and adenovirus receptor (CAR). 2 In this regard, CAR functions as the major pathway of Ad5 cell recognition and entry by mediating attachment of the viral fiber protein to cell surface followed by interaction of capsid penton base with cellular integrins triggering subsequent virus internalization. 3 In order to circumvent the problem of limited infection of cancer cells by Ad5, viral tropism can be modified to retarget Ad5 to an alternate receptors thereby rendering viral infection CAR-independent. This can be achieved by modification of several capsid proteins of the virion. The most commonly employed site for Ad5 capsid modification is the fiber protein knob domain. 4 Genetic modification of the knob can be achieved either by incorporation of a peptide ligand with a distinct receptor binding specificity or by a serotype chimerism approach that involves replacement of the entire knob domain by that of an alternate Ad serotype, which recognizes a non-CAR primary receptor. 5 Several studies have shown that CAR-independent gene delivery can be achieved by incorporating a short peptide ligands into two distinct locales of the knob: HI-loop 6 or carboxy (C)-terminus. 7, 8 Owing to the structural constraints imposed by incorporated ligands on knob folding and fiber trimerization, only a limited number of genetic modifications at these locales have allowed production of functional fiber, and ultimately an infectivity-enhanced virus. In addition, serotype chimerism has been demonstrated to accomplish CAR-independent entry with infectivity enhancement. 5, 9, 11, 12 The most recent additional approach has employed a combination of two different functional ligands genetically incorporated in two distinct locales of a single-fiber knob. This approach has proved to be useful as it has allowed an additional infectivity enhancement of the Ad5 vector due to the additive effect of dual-receptor targeting via both ligands within a single fiber molecule. 13 This type of fiber modification that combines several different genetically incorporated ligands in a single-fiber molecule has been termed ''complex mosaicism''.
Herein we propose a logical extension of the complex mosaicism strategy, which combines knob serotype chimerism with ligand incorporation at one or two distinct locales of the fiber knob. The two important advantages of our strategy are: (i) it potentially allows combining targeting specificities of a short peptide ligands and fiber knobs of various Ad serotypes potentially creating a significantly broader spectrum of targets for Ad-based gene therapy, and (ii) it avoids the potential problem of CAR dependence of the Ad5 tropism. We have evaluated the utility of this novel type of genetic capsid modification for adenoviral vector targeting by using various cancer cell lines as a targeting models.
Materials and methods

Cell culture
Bladder cancer cell lines T24, SW780, RT4 and J82 were obtained from American Type Culture Collection (ATCC) and maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS), 100 U/ml ampicillin and 100 mg/ml streptomycin. G-361 cell line (skin carcinoma), HEY and SKOV-3 (ovarian cancer) were obtained from ATCC. Cell line LNCaP (prostate cancer) was obtained from Cell Genesys Inc. LNCaP, HEY and SKOV-3 were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% FBS, 100 U/ml ampicillin and 100 mg/ml streptomycin.
The 293 cell line (human embryonic kidney cells containing E1 region of Ad5) was obtained from ATCC. Its maintenance conditions were the same as for LNCaP cell line described above.
Construction of the modified fiber genes
Fiber genes with various modifications incorporated by site-directed mutagenesis were assembled within mammalian pVS expression vectors designed for high-level transient expression of proteins in mammalian cells.
(i) Generation of the vector expressing the Ad5 fiber with c-terminal RGD motif. In assembling this construct, we used the expression plasmid pVS.F LL /Bae. This vector contains a unique BaeI recognition sequence within the site of insertion, which upon cleavage with BaeI results in unique, noncomplementary sticky ends, thereby facilitating directional cloning of the ligand-encoding sequences. A 27 nt-long oligonucleotide duplex encoding CDCRGDCFC peptide (RGD-4C) with 5 nt 5 0 overhangs at each end was cloned into BaeI-cleaved F.5 LL /Bae (pVS). This resulted in F.5 LL -RGD (pVS), which incorporates a gene encoding the Ad5 fiber modified at the C-terminus with RGD-4C.
The fiber and the ligands were fused by a short linker peptide [G 4 S] 3 (GGGGSGGGGSGGGGSCDC RGDCFC). 14 (ii) Generation of the vector expressing the Ad5 fiber with the RGD motif in the HI loop. This plasmid was designed using the previously made fiber-RGD gene assembled within the fiber shuttle vector pNEB.PK.F HI -RGD. 15 The fiber-RGD gene was isolated from the pNEB.PK.F HI -RGD as an AgeI-MfeI-fragment and transferred into AgeI/MfeI-cleaved pVS vector, resulting in F.5 HI -RGD (pVS) construct.
(iii) Generation of the vector expressing the Ad5 fiber with two copies of an RGD motif. In order to combine both of the above RGD modifications of the fiber within a single construct, we have replaced a segment of the F.5 LL -RGD gene, which encodes the HI loop and adjacent sequences, with a similar fragment derived from F.5 HI -RGD (pVS). First, we employed the ''sticky-end PCR'' 16 to amplify the desired portion of F.5 HI -RGD (pVS) and add the BstXI-compatible sticky ends to the product. Next, we cloned this fragment in place of a BstXI-segment of pVS.Fb5 LL RGD, thereby substituting the original (wild type) sequence of the HI loop within the fiber with that incorporating the RGD-4C peptide. The new plasmid vector was designated F.5 HI þ LL -RGD (pVS).
(iv) Generation of the vector expressing the Ad5/3 fiber with RGD-4C in the HI loop. For this purpose, we made use of the previously designed gene encoding the chimeric F.5/3 fiber contained in the pNEB.PK.F5/3 shuttle vector 5 and used it as a template for PCR in order to introduce the RGD-4C-encoding sequence within the HI loop of the Ad3 fiber knob domain. This was accomplished in a two-sep procedure whereby the regions of the pNEB.PK.F5/3 immediately adjacent to the site of incorporation (flanked by the Arg544 and Arg549 codons of the Ad3 fiber gene sequence) were first PCR-amplified such that the RGD-4C coding sequence was incorporated into both PCR products. Subsequent to that, both PCR products were mixed and used as a template in an overlap-extension PCR employing a pair of primers having the annealing sites distal to the site of RGD-4C insertion. The resulting product was then cleaved with XbaI and MfeI and cloned into XbaI/MfeI-digested F.5WT (pVS), resulting in F.5/3 HI -RGD(pVS). Of note, in the F.5/3 HI -RGD protein the RGD-4C peptide replaces an LPDS sequence of the Ad3 fiber knob.
(v) Generation of the vector expressing the Ad5/3 fiber with c-terminal RGD motif. A strategy similar to the one used to make the F.5/3 HI -RGD gene was employed to assemble the F.5/3 LL -RGD-encoding sequence within pVS vector. This time, two DNA fragments were PCRamplified using two different plasmid templates: the sequence encoding [G 4 S] 3 linker and RGD-4C ligand was amplified from F.5 LL -RGD (pVS) construct as a template. The 3 0 portion of the F.5/3 gene, which is located downstream from the XbaI site, was amplified with F.5/3(pVS) serving as a template. As the required sequences had no homology, an overlap corresponding to the 3 0 of the Ad3 fiber gene has been engineered into both PCR products by incorporating relevant nucleotides into the primers used for amplification. PCR products obtained in this manner were mixed and used for the overlap-extension PCR with a pair of ''external'' primers. The resulting product was cleaved with XbaI and MfeI and cloned into F.5/3(pVS) to generate F.5/3 LL -RGD (pVS).
(vi) Generation of the vector, expressing Ad5/3 fiber with two copies of the RGD motif. The plasmid encoding the double-modified fiber chimera F.5/3 HI þ LL -RGD (pVS) was engineered in the same manner as was F.5/3 LL -RGD(pVS), except that the F.5/3 HI -RGD (pVS) was employed as a source of the HI loop-encoding region instead of F.5/3 (pVS). Identity of all modified fiber genes was confirmed by sequencing. Sequences of all oligonucleotides used as primers for mutagenic PCR are available on request.
Generation of shuttle vectors containing modified fiber genes
All shuttle vectors designed in this work were derived from the previously made pKAN3.1 vector, which is a derivative of pZeRo.Kan (Invitrogen) containing a 3.1 kb XbaI-KpnI fragment of Ad5 genome comprising the fiber gene and the adjacent Ad5 genomic sequences. These flanks facilitate homologous recombination between the shuttle vector with the same sequences present in pVK rescue vectors (below). To transfer the modified portions of fiber genes from pVS expression vectors into pKAN3.1, the AgeI/MfeI-fragments corresponding to nearly complete fiber genes were transferred from pVSderivatives and cloned in place of the homologous AgeIMfeI-fragment of pKAN3.1.
Incorporation of the modified fiber genes into the genome of replication-deficient, luciferase-expressing Ad vector
Rescue vectors incorporating Ad5 genomes with various modified fiber genes were designed by homologous recombination in the recombination prone Escherichia coli BJ5183 as described previously. 17 This was accomplished by using pVK700 rescue vector, which contains the genome of Ad5 with the E1 region replaced with the firefly luciferase-expressing cassette driven by CMV promoter. Additionally, the fiber gene within pVK700 is mostly deleted and replaced with a SwaI linker. To transfer the RGD-modified fiber genes from the pKAN3.1-derived plasmids into pVK700, E. coli BJ5183 cells were cotransformed with a mixture of EcoRIlinearized shuttle vector and SwaI-linearized pVK700. Plasmid DNA was isolated from clones after Amp selection and after confirmation of its size and the presence of the modified fiber genes by PCR was retransformed into E. coli Stbl2 strain to ensure the stable maintenance of the rescue plasmids. Ampicillin selection prevented potential background that could be generated by pKAN-shuttle vectors bearing kanamycin but not ampicillin resistance gene.
The presence of the fiber gene within the resulting rescue vectors was confirmed by partial sequencing.
Ad vector rescue, propagation and purification
The newly derived Ad genomes were released from the rescue plasmids by PacI digestion and used for transfection of 293 cells to rescue Ad vectors as described previously. 6 Rescued vectors were plaque purified and further propagated on 293 cells by several rounds of infection until at least 10 8 cells were infected with each viral vector. Purification of the viruses was carried out by double CsCl gradient centrifugation, followed by two-step dialysis. Virus concentration was determined by spectrophotometry at A 750 with DC Protein assay kit (Bio-Rad) and verified by measuring nucleic acid concentration at A 260 .
Immunoblotting
The lysates of 293T cells transiently transfected with fiber expressing pVS vectors were prepared 48 hours posttransfection and analyzed by denaturing 10% PAGE. To analyze trimerization efficiency/trimer stability of the modified fibers, 10 ml of lysates or B2-5 Â 10 9 of CsClpurified viral particles (vp) were loaded on each gel lane with and without prior denaturation by boiling in SDSsample buffer. Then proteins were electro-transferred onto PVDF membrane. Western blot assay was carried out by using ''Westernbreeze'' chemiluminescent immunodetection kit (Invitrogen) and 4D2 antifiber tail monoclonal antibody 18 as a primary antibody. Trimeric as well as monomeric fiber protein (upon sample boiling) for each virus was normalized by other capsid proteins in the same samples revealed by total protein staining with ''gelcode blue'' stain (Pierce).
In vitro analysis of the viral infectivity
For gene transfer experiments, cells were seeded on 24-well plates (for LNCaP polylysine-coated plates were used) with a density of 1.5 Â 10 5 -2.5 Â 10 5 cells/ml/well and grown for 24-72 hours depending on cell line growth rate until confluency. Prior to gene transfer, cells were washed once with 1 ml of 2% FBS-RPMI and 200 ml of 2% FBS-RPMI or the same volume of purified recombinant Ad5-or Ad3-fiber knob protein in the same medium with concentration 0.1 mg/ml was added to each well. Incubation for knob blocking was carried out at room temperature for 30 minutes. Purified Ad3 knob was kindly provided by Dr J Short.
For gene transfer, 200 ml of diluted virus in 2% FBS-RPMI (2% FBS-DMEM for LNCap and 293 cells) was added to the wells and incubation continued for another 30 minutes. Medium containing virus was removed and the cells were washed once with 1 ml of the 10% FBSmedium and incubation continued in the same medium Cells were lysed in 500 ml of cell Culture Lysis Reagent (Promega, Madison, WI), after a single freeze-thaw cycle. The luciferase assay was carried out using luciferase substrate from Luciferase Assay System (Promega, Madison, WI) according to the manufacturer's instructions. Luciferase activity in lysated was measured by luminometer Femtomaster FB-12 (Zylux Corporation, Maryville, TN) by using STLS-Protocol Manager software.
Statistical analysis
Statistical analysis of Ad virus infectivity was performed in a two-tailed t-test. Data are expressed as mean7SD of at least three sets of results. Results were considered statistically significant when Po.05.
Results
Construction of genetically modified Ad5 fibers by using a new type of complex mosaicism approach
To incorporate the integrin-binding RGD motif-containing RGD-4C peptide in the knob domain of Ad3, we used a chimeric fiber construct (F.5/3), bearing tail and shaft domains of the Ad5 fiber fused to knob domain of the Ad serotype 3 (Ad3) fiber. In order to explore different locales of the Ad3 knob for suitability of ligand incorporation, we placed the RGD-containing peptide in its HI loop, C-terminus or both locales simultaneously. Cterminal modification was added to the knob sequences via a 15-amino-acid linker [G 4 S] 3 to achieve better exposure and accessibility of the RGD motif on the knob surface.
Identical modifications were created in parallel in the context of Ad5 knob (F.5-modification series) for comparison and also to increase diversity of modified fiber variants and their receptor-binding characteristics. Both peptide modifications were introduced into the fiber knob sequences by means of PCR-based mutagenesis in the context of fiber encoding mammalian expression vectors of the pVS series. Therefore we designed a total of six new RGD-modified fiber proteins, studied along with the corresponding nonmodified wild type (F.5WT) and chimera (F.5/3) fiber controls. The entire set of modified fibers used in this work for tropism modification of Ad vector is schematically depicted in Figure 1 .
Fibers with complex mosaic modifications are capable of trimerization
Analysis of the trimerization of modified fiber is an important indicator of their potential functionality and successful capsid incorporation upon virion assembly. In order to assess the trimerization property of the recombinant fibers, the human 293T cells were transfected with each of the expression pVS-vectors. The F.5WT (pVS) vector, expressing wild-type Ad5 fiber gene, was used in these experiments as a positive control.
As shown on Figure 2a , lysates from human tissue culture cells (293 T) expressing each of the modified fiber, all produce a trimeric form of the fiber with various trimer-to-monomer ratios. The modified fibers F.5 LL -RGD and F.5 HI þ LL -RGD with double RGD modification exhibited the lowest trimerization ability. Somewhat different properties were observed for the chimeric F.5/3 fiber series with F.5/3 HI -RGD, showing the least trimerization (Fig 2a, right panel) . The data altogether suggest that none of the RGD modifications in the context of either wild-type (F.5WT) or chimeric (F.5/3) fiber abolishes trimerization of the protein. Judging by rather high amount of fibers in trimeric configuration present in lysates we hypothesized that all the modified fiber proteins were likely to incorporate into Ad particles.
Fibers with complex mosaic modifications are efficiently incorporated into the viral capsids
In order to verify that the modified fibers do not interfere with the assembly of viral particles, we incorporated modified fiber genes into the Ad5 genome. To this end, the modified fiber genes were subcloned into adenoviral vector shuttle plasmids in order to allow subsequent homologous recombination of the shuttle with Ad genome of the pVK700 rescue vector. Ad5 genomes carrying the modified fiber genes were created by homologous recombination in the recombination-prone E. coli strain.
All the viruses were successfully rescued in 293 cells, propagated to preparative amounts and double purified in CsCl gradients. Comparative analysis of virus yields, summarized in Table 1 , suggests that virus production is not drastically affected by the fiber modifications and is only reduced from 1.4-to 8-fold depending on modification. Incorporation of the modified fibers into the viral capsids was verified by immunoblot analysis of the double CsCl-purified Ad particles: Western blot of fiber complexes from purified virions demonstrated that, despite unequal trimerization abilities observed in cell lysates, all the modified fibers were present in the virions in amount comparable to that of the wild-type fiber (Fig 2b) . The production of the fiber-modified viruses (virus yield) in 293 cells was generally found to be in agreement with the trimerization ability of the corresponding modified fibers ( Table 1, Fig 2) .
Incorporation of the RGD-ligand at the C-terminus of the Ad3 fiber knob does not prevent its functionality in integrin targeting
In order to check functionality of the RGD-ligand incorporated into HI loop or at C-terminus of the Ad3 knob, we performed a gene transfer experiment in CHO cells known to express a v b integrins but not CAR or Ad3 receptor. 19, 20 Using these cells would allow us to better assess Ad infectivity mediated by the RGD-4C modification in the Ad3 knob and distinguish it from the one mediated by the knob interaction with its major natural receptor (Ad3 receptor).
In order to verify the absence of CAR and Ad3 receptor-mediated interactions for the Ad vectors in CHO cells, we performed Ad5 and Ad3 knob blocking in the same experiment. While Ad5 knob protein was capable of efficiently blocking gene transfer of the F.5WT virus in CAR-expressing 293 and G-361 cell lines (data not shown), it demonstrated no blocking effect for any of the viruses in CHO cells in the same experiment (Fig 3,  white bars) . Similarly, while the functional activity of the Ad3 knob protein was evidenced by its blocking effect on the F.5/3 virus infection in the Ad3 receptor-expressing G-361 cells (data not shown), it did not block infection of CHO cells by any of the fiber-modified or nonmodified viruses under the same blocking conditions (Fig 3, black  bars) . These results are consistent with no contribution of CAR or Ad3 receptor to the Ad infectivity in CHO cells. As can be also seen from Figure 3 , the level of gene transfer for both F.5WT and F.5/3 control viruses in CHO cells (hatched bars) is comparable and very low, and may reflect some background (both fiber and non fiber mediated) interactions detectable in the absence of binding to the major Ad receptors.
A drastically different picture was observed for some RGD-modified viruses suggesting functional contribution of the genetically incorporated ligand. Functionality of the Ad3 knob C-terminal modification was evidenced by a pronounced (B3-4-fold) augmentation of infectivity seen for the complex mosaic F.5/3 LL -RGD virus as compared to the F.5/3 chimera control. Moreover, a significant infectivity enhancement can be seen also for the vector with double RGD-modified fiber F.5/3 HI þ LL -RGD (Fig  3) . In contrast, the RGD-peptide incorporated into the HI loop of the Ad3 knob in the context of F.5/3 chimera not only failed to provide augmentation but strongly reduced gene transfer, suggesting that the ligand incorporation in this locale is inhibitory for the virus infectivity (Fig 3, F5 / 3 HI -RGD).
In the above experiment, we also used identical fiber modifications in the context of Ad5 fiber knob for comparison since the RGD-4C ligand had already been demonstrated to function in integrin targeting when incorporated into the HI loop or C-terminus of the F.5 knob. 15 As expected, we observed a dramatic infectivity enhancement for the F.5 HI -RGD modification of nearly two orders of magnitude (Fig 3, F.5 HI -RGD) , which served as a positive control for the ligand functionality in CHO cells. In contrast to the HI loop modification, the modification at C-terminus or the double RGD modification of the F.5 knob provided a significantly weaker (Figs 4  and 6 ) with the strongest relative enhancement seen in T24 bladder cancer cell line which has the lowest level of CAR expression (Figs 5 and 6) .
Remarkably, the strongest infectivity enhancement was observed for the virus carrying a complex mosaic fiber F.5/3 LL -RGD with Ad3 knob C-terminal RGD as well as for the virus with the chimeric fiber F.5/3 alone. The observed infectivity enhancement for the F.5/3 virus in T24 cells was 38-fold as compared to F.5WT, whereas augmentation observed for the F.5/3 LL -RGD mosaic virus was 55-fold ( Figs 5 and 6) .
The other RGD-modified chimeras provided either no or much weaker infectivity enhancement relative to F.5WT virus, and even showed a significant reduction of infectivity when compared to the F.5/3 virus with no RGD modification in all the analyzed cancer cell lines (Figs 4 and 6) .
As demonstrated by the blocking experiments with purified recombinant Ad5 fiber knob domain, the augmentation seen for viruses of the F.5/3 series is not mediated by CAR (Fig 4, white bars) and is likely to be due to other receptors, which are likely to include the Ad3 receptor (see below).
Enhanced infectivity of Ad vectors bearing F.5/3 chimera in various cancer cells is mediated by Ad3 receptor and is not prevented by C-terminal RGDmodification
In order to verify that infection of F.5/3 containing viruses was indeed mediated by Ad3 receptor, we carried out a gene transfer blocking experiments with purified recombinant Ad3 fiber knob domain. For these experiments, we chose T24 bladder cancer cell line in which we observed the most pronounced enhancement of infectivity for viruses with modified fibers including the complex mosaic F.5/3 LL -RGD.
In addition to the Ad3 fiber knob, we also performed gene transfer blocking with the recombinant Ad5 fiber knob for the side-by-side comparison of the different knob effects in the same experiment. The results showed that while competition with Ad5 fiber knob had no effect on infection by any of the viruses with chimeric F.5/3, preincubation with the same amount of Ad3 knob resulted in a discernible inhibition of viral infectivity, the extent of which varied depending on the site of RGDligand incorporation (Fig 5) . This comparison clearly shows that the mechanism of infection of bladder cancer cells by viruses of the F.5/3-series involves interaction with Ad3 receptor apparently well expressed in those cells.
Although addition of Ad3 fiber knob to T24 cells prior to virus infection exerts an inhibitory effect on infection by all the F.5/3-based Ad vectors, the relative effect of that inhibition is different for some viruses. Remarkably, the only virus with complex mosaic F.5/3 LL -RGD modification that at least does not show a reduced infectivity relative to F.5/3 control in T24 cells appears to be more resistant to Ad3 knob inhibition than the control virus (Fig 5) . This result provides an additional evidence that the RGD-4C peptide placed at the C-terminus of the chimeric fiber Ad3 knob is functional and contributes to infectivity of the virus with the complex mosaic modification, making it relatively less dependent on Ad3 receptor.
The opposite effect was observed for the viruses of the F.5 series, which demonstrated various degrees of infectivity inhibition by Ad5 fiber knob but were absolutely not affected by Ad3 fiber knob (Figs 5 and 6, T24 panel), in line with the fact that the major pathway of infection used by the viruses of F.5 series involves CAR but not the Ad3 receptor.
Viruses with double RGD-modification of the Ad5 fiber knob exhibit low CAR-dependence
As demonstrated by the gene transfer experiment shown in Figure 4 , none of the RGD-modifications in the context of nonchimeric F.5 fiber enhanced Ad5 infectivity in prostate (LNCaP) or melanoma (G-361) cancer cell lines. The only RGD modification in F.5 fiber knob that provided significant enhancement in some bladder and ovarian cancer cells is F.5 HI -RGD with the HI loopincorporated RGD peptide (Fig 1) . The effect was especially pronounced in CAR-deficient T24 bladder cancer cells as well as ovarian cell lines SKOV-3 (data not shown) and HEY (Fig 4) with infectivity augmentation levels ranging from 6-to14-fold in different experiments (Figs 5 and 6 ) The other C-terminal RGDmodification of the F.5 knob provided either no discernible enhancement (Fig 4, HEY panel; Fig 6, T24 , J82 panels) or even caused significant inhibition of Ad infectivity (Fig 4, 293 , G-361, LNCaP panels and Fig 6,  RT4, SW780 panels) . The double modification in F.5 fiber was mostly associated with decreased infectivity; however, we could observe some augmentation in T24 bladder and HEY ovarian cell lines for F.5 HI þ LL -RGD virus.
In sharp contrast to the Ad vectors carrying RGDmodified or nonmodified F.5/3 fibers, infection by most F.5-based viruses demonstrates various extent of CARdependence as revealed by discernible gene transfer blocking effect of the recombinant Ad5 knob (also see above). However, the relative sensitivity of gene transfer by the RGD-modified F.5 viruses to Ad5 knob blocking was clearly reduced as compared to that by F.5WT control virus. The least sensitivity to Ad5 knob blocking was displayed by infection with F.5 HI þ LL -RGD virus carrying a double-RGD modified fiber in all analyzed cancer cell lines (Fig 4) . This observation is consistent with the possibility of complete or partial ablation of CAR-dependent cell interaction due to the multiple ligand interference effect.
As can be seen from all panels in Figures 4, 5 and 6 (white bars), when CAR-mediated component of virus infectivity was blocked by Ad5 knob all the F.5 modified viruses showed a pronounced or even dramatic infectivity enhancement relative to the F5.WT control, including the double RGD-modified virus, suggesting that the RGDligand on the F.5 knob is functional and contributes to virus infectivity to a various extent depending on the number of modifications and the site of incorporation.
It is noteworthy that, the pattern of relative infectivity for the RGD-modified F.5 viruses under the Ad5 knob blocking conditions (white bars in Figs 4, 5 and 6), which was utilized to mimic the absence of CAR-mediated interaction in cancer cells with various CAR levels, closely resembles the gene transfer pattern observed in the absence of knob blocking in CHO cells devoid of CAR (Fig 3) .
All differences in gene transfer levels observed between the fiber-modified Ad mutants and the virus with wild type fiber were statistically significant (Po.05).
Discussion
Recent observations suggest that expression of certain cellular receptors including a v b integrins and Ad3 receptor, recently identified as CD80 (B7.1) and CD86 (B7.2) costimulatory molecules, is upregulated in many primary cancer cells and thus the above receptors could potentially be utilized for targeting of Ad5-based vector to cancer cells. 22 Based on this notion our strategy aimed at broadening receptor-binding properties of Ad5 vector to simultaneously target it to integrins and Ad3 receptor on the surface of cancer cells using melanoma, prostate as well as ovarian and bladder cancer cell lines as a targeting model.
The present study addresses the possibility of infecting cancer cells by Ad vector bearing multiple genetic modifications to mediate dual-receptor interaction with the target cells in CAR-independent fashion. To achieve that we chose a combination of fiber knob replacement strategy or ''serotype chimerism'' with short peptide ligand incorporation in the knob domain of the chimera. We constructed series of capsid-modified Ad5 vectors with new targeting properties, which combined natural tropism of adenovirus serotype 3 (Ad3) with the ability of a short RGD-motif containing peptide CDCRGDCFC to bind integrins. This novel combination of genetic modifications we termed complex mosaicism is distinct from the mosaic modification whereby two different ligands (RGD and pK7) are configured in different locales of a single fiber knob, as recently reported by Wu and colleagues (see above). Although both chimeric F.5/3 and RGD-modified F.5 fibers, as a separate capsid modifications, have been successfully used in gene therapy applications, the effect of combining both types of genetic modifications in a single-fiber molecule has not been explored before and represents a novel development in the complex mosaicism approach.
Feasibility of Ad3 knob C-terminal modification in the context of F.5/3 fiber and its functionality in the ligandmediated targeting has been recently demonstrated by Uil et al, 23 who used an artificial ligand (6His-tag) for the proof-of-principal. However, it remained unclear if natural ligands such as RGD-peptide placed at this locale or in HI loop would function in integrin targeting and if they would interfere with its cognate (Ad3) receptor binding. To address these questions in the present study, we endeavored genetic incorporation of the RGD-4C peptide in each or both of the two locales: HI loop and Cterminus of the Ad3 knob. Since the double RGD modification of any fiber knob has never been reported before, it was also of a particular interest to compare its effect with those of each single modification.
Although most modifications somewhat impair trimerization properties of the fiber, all the modifications appear to be compatible with adenovirus production and capsid assembly (Fig 2) . Comparison of the modified virus production (Table 1) demonstrates direct correlation with the modified fiber trimerization ability.
The data we present in this study suggest that the Cterminal incorporation of the RGD-4C ligand is compatible with the Ad3 knob binding to its cognate receptor as F.5/3 LL -RGD is the only RGD modification of Ad3 knob, which not only does not reduce infectivity of the chimera vector, but even slightly increases it in some cancer cells (Fig 4, panels G-361, LNCaP; Figs 5, 6 ; panels T24, J82).
In contrast, incorporation of the ligand in HI loop or both HI loop and C-terminus of the Ad3 knob simultaneously reduces vector infectivity in all the cell lines. This could be either due to the steric hindrance or conformational alterations at the Ad3 receptor-interacting interface of the knob domain caused by genetic incorporation of the RGD-ligand in the particular knob locale(s).
It is noteworthy that effects of HI loop-incorporation of the RGD-ligand are markedly different for Ad5 and Ad3 fiber knobs. While HI loop modification in Ad3 knob elicits a significant (B3-5-fold) inhibition of vector infectivity, the same modification in the Ad5 knob does not interfere with the intrinsic CAR-binding property of Ad5 knob in some cancer cell lines and can even display a strong augmentation of viral transduction, ranging from 15-to 50-fold, under conditions of CAR-deficiency (as in CAR-deficient T24 bladder cancer cell line or upon competition with Ad5 knob).
Thus our experiments demonstrate that the RGDpeptide incorporated at certain locales of the Ad5 or the Ad3 fiber knobs does interfere with their functionality. In line with that our experiments demonstrate that double RGD modification in any of the above types of fiber can only reduce virus infectivity as compared to modifications at each of the locales alone and never result in any additive effect.
Although incorporated RGD-ligand can somewhat reduce affinity of Ad3 or Ad5 knobs for their cognate receptors (Ad3 receptor and CAR, respectively), the ligand itself can positively contribute to viral infectivity via binding to cellular integrins. In order to estimate contribution of that interaction to infectivity of the RGDmodified F.5/3 virus, which is still retaining natural affinity to the Ad3 receptor, it was necessary to eliminate the knob interaction with its natural receptor. A straightforward way to achieving that was using CHO cell line, which lacks Ad3 receptor, for gene transfer experiment.
As could be predicted, in the absence of Ad3 receptor the contribution of RGD-ligand to virus infectivity becomes a dominant type of virus-cell interaction and thus much more pronounced. Although a positive contribution of the RGD-ligand under such conditions is better revealed for the HI loop-modified F.5 knob (Fig  3, F .5 HI -RGD), it could be clearly visualized also for Ad3 knob in the F.5/3 chimera context (Fig 3, F.5/3LL-RGD) . The lack of discernible Ad5 or Ad3 knob blocking effects in CHO cells is consistent with the lack of CAR and Ad3 receptors on those cells and argues for integrin-mediated nature of the infectivity enhancement observed in this experiment.
On the other hand, the experiment in CHO cells (Fig 3) demonstrates that the integrin-binding property of the RGD-ligand placed in HI loop of the Ad3 knob is compromised as opposed to the similar modification in the Ad5 knob, suggesting that the HI loop locale of the Ad3 knob is less suitable for the RGD-ligand incorporation than its C-terminus.
It is important to note that the infectivity enhancement we observed for the RGD-4C modification in the HI loop locale of the F.5 knob in some bladder and ovarian cancer cells is consistent with the data on HI loop-modified Ads in various cancer cells reported by others. 12, 15, [24] [25] [26] Thus our data indicate that due to some structural features the Ad3 knob is more refractory to genetic incorporation of the RGD-4C peptide than the Ad5 fiber knob domain.
One of the advantages of the complex mosaicism approach in fiber modification lies in the possibility of achieving an additive effect of dual receptor targeting. 13 In fact, none of the complex mosaic modifications tested in this study showed any significant additive effect as could be anticipated. It is possible, though, that the effect of F.5/3 LL -RGD modification observed in our experiments also represents a combined result of RGDmediated infectivity enhancement superimposed on partial inhibition of Ad3 knob binding to its cognate receptor, caused by the ligand incorporation. Thus, possible partial inhibition of any of the receptor-binding properties of the complex mosaic fiber due to genetic ligand incorporation can explain our failure to observe a strong additive effect of the dual-receptor interaction of the vector with target cells.
Infectivity enhancement we observed in this study for the F.5/3 chimera was generally consistent with other reports on the F.5/3 chimera-mediated infectivity in cancer cells. 5, 9, 11, 12, 27, 28 In fact, F.5/3 provided consistently stronger augmentation of infectivity than the HI loop-modified F.5 knob in all cancer cell lines analyzed in this study. A complete resistance of all the F.5/3 chimerabased vectors to recombinant Ad5 knob blocking, on the one hand, but clear sensitivity to the recombinant Ad3 knob, on the other, as illustrated by Figure 5 , demonstrates ablation of CAR-tropism and strongly suggests that the major interaction of the F.5/3 viruses with cancer cells involves the Ad3 receptor. However, given the functionality of the RGD-4C ligand, especially in the context of Ad3 knob C-terminal modification, the contribution of RGD-mediated integrin-targeting to the overall infectivity of the modified virus is quite obvious.
Thus we conclude that Ad fibers with complex mosaic knob modifications combining serotype chimerism and genetic incorporation of the RGD-ligand can be used to retarget Ad5 vectors to two distinct cancer-associated markers such as Ad3 receptor and a v b integrins simultaneously, while completely eliminating CAR-dependence in vector tropism. Although we observed a relatively small advantage of the complex mosaic modification over the serotype chimerism modification alone in the cancer cell lines used for our experiments, this new type of genetic modification of the fiber could potentially have a much greater advantage in some other types of cancer expressing a different Ad3 receptor/integrin ratio on the cell surface.
Development of new approaches to genetic modification of Ad5 fiber is important due to the potential utility of such modifications for subsequent construction of infectivity enhanced conditionally replicative adenovirus (CRAd) agents with cancer-targeted replication properties 29, 30 In fact, genetic modification of fiber, as opposed to the immunologic approach based on using a separate conjugate adaptor molecules for vector targeting (reviewed in Curiel 4 ), can be used to infectivity enhance CRAd agent, since only the former type of modification would confer the improved infectivity also to viral progeny and thereby support efficient spread of infectivity enhanced CRAd from the initial site of infection.
Thus establishing a novel type of Ad5 fiber genetic modification such as complex mosaics capable of combining various receptor binding properties in a single fiber molecule, compatible with virus assembly and propagation, broadens the spectrum of potential cancer targets for the oncolytic virotherapy agents such as CRAds and could greatly improve future of cancer therapy.
